Unadjusted | Adjusted | ||||
---|---|---|---|---|---|
CT/TT | CC | Pa | aOR (95% CI) | pb | |
(A) rs6897932 | |||||
F ≥ 3 | 20.5% (17/83) | 23.4% (32/137) | 0.619 | 1.14 (0.54;2.32) | 0.735 |
APRI ≥1.5 | 15% (12/80) | 18.6% (24/129) | 0.502 | 1.14 (0.48;2.68) | 0.770 |
FIB4 ≥3.25 | 10% (8/80) | 9.3% (12/129) | 0.868 | 0.80 (0.25;2.56) | 0.705 |
A3 | 4.9% (4/82) | 14.9% (20/134) | 0.023 | 4.16 (1.19;14.59) | 0.026 |
Unadjusted | Adjusted | ||||
---|---|---|---|---|---|
AA/AT | TT | Pa | aOR (95% CI) | pb | |
(B) rs987106 | |||||
F ≥ 3 | 18.8% (32/170) | 34.7% (17/49) | 0.019 | 3.09 (1.32;7.22) | 0.009 |
APRI ≥1.5 | 14.3% (23/161) | 27.7% (13/47) | 0.033 | 1.84 (0.72;4.70) | 0.201 |
FIB4 ≥3.25 | 7.5% (12/161) | 17% (8/47) | 0.050 | 2.33 (0.67;8.05) | 0.181 |
A3 | 10.1% (17/168) | 14.9% (7/47) | 0.358 | 1.82 (0.63;5.23) | 0.269 |
Unadjusted | Adjusted | ||||
---|---|---|---|---|---|
AG/GG | AA | Pa | aOR (95% CI) | pb | |
(C) rs3194051 | |||||
F ≥ 3 | 16.7% (20/120) | 29.3% (29/99) | 0.026 | 2.73 (1.22;5.87) | 0.010 |
APRI ≥1.5 | 11.5% (13/113) | 24.2% (23/95) | 0.016 | 2.52 (1.10;5.77) | 0.029 |
FIB4 ≥3.25 | 5.3% (6/113) | 14.7% (14/95) | 0.022 | 4.01 (1.17;13.71) | 0.027 |
A3 | 12.6% (15/119) | 9.4% (9/96) | 0.455 | 0.79 (0.30;2.10) | 0.634 |